Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Relevance of the Pathologic Regression in Lymph Node for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Multi-center Study

NCT06883084 is registered in ClinicalTrials.gov with Yanhong Deng as lead sponsor.

NCT NCT06883084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06883084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Relevance of the Pathologic Regression in Lymph Node for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Multi-center Study
Lead sponsor
Yanhong Deng
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 30, 2014
Completion date
February 25, 2026
Enrollment
1,080 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastasis, rectal cancer